Oxytocin Administration Increases Proactive Control in Men with Overweight or Obesity: A Randomized, Double‐Blind, Placebo‐Controlled Crossover Study. Issue 1 (22nd November 2020)

• Record Type: Journal Article
• Authors: Plessow, Franziska; Marengi, Dean A.; Perry, Sylvia K.; Lawson, Elizabeth A.
• Is Part Of: Obesity. Volume 29:Issue 1(2021)
• Page Start: 56
• Page End: 61
• Publication Date: 2020-11-22
• Subjects: Obesity -- Periodicals; 616.398005
• DOI: 10.1002/oby.23010
• Languages: English
• ISSNs: 1930-7381

Abstract

Abstract : Objective: Preclinical and clinical evidence suggests that oxytocin administration decreases food intake and weight. The mechanisms underlying the anorexigenic effects of oxytocin in humans are unknown but critical to study to consider oxytocin as a neurohormonal weight loss treatment. Complementing ongoing research into metabolic and food motivation mechanisms of oxytocin, this study hypothesized that in humans, oxytocin improves cognitive control over behavior. Methods: In a randomized, double‐blind, placebo‐controlled crossover study of 24‐IU single‐dose intranasal oxytocin, 10 men with overweight or obesity completed a stop‐signal task assessing ability and strategy to suppress behavioral impulses, in which they performed a choice‐reaction task (go task) but had to withhold their response when prompted (stop task). It was hypothesized that oxytocin would improve suppression of behavioral impulses. Results: After receiving oxytocin, compared with placebo, participants showed increased reaction times in the go task (mean [M] = 936 milliseconds vs. 833 millseconds; P = 0.012; 95% CI: 29 to 178) and displayed fewer stop errors (M = 36.41% vs. 41.15%; P = 0.049; 95% CI: −9.43% to −0.03%). Conclusions: Oxytocin triggers increased proactive control over behavior. Future studies need to further characterize the impact of oxytocin on cognitive control and investigate its potential role in the anorexigenic effects of oxytocin in human obesity.